Following the success of 3 randomized trials and 1 open-label extension trial, the US Food and Drug Administration has approved a new sublingual tablet for the treatment of certain adults with nocturia.
...
Following the success of 3 randomized trials and 1 open-label extension trial, the US Food and Drug Administration has approved a new sublingual tablet for the treatment of certain adults with nocturia.
...
Following the success of 3 randomized trials and 1 open-label extension trial, the US Food and Drug Administration has approved a new sublingual tablet for the treatment of certain adults with nocturia.
...
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
